| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009517 Use of nelfinavir as a radiation sensitizer |
| 01/10/2008 | US20080009511 Cancer treatment with compounds inhibiting PKC alpha |
| 01/10/2008 | US20080009509 Quinazoline Derivatives For Inhibiting Cancer Cell Growth And Method For The Preparation Thereof |
| 01/10/2008 | US20080009507 Cancer; such as 2-[4-(1-amino-1-methylethyl)phenyl]-3-(2-thienyl)-1,6-naphthyridin-5(6H)-one; serine/threonine kinase (Akt) suppression |
| 01/10/2008 | US20080009497 Pyrrolotriazine kinase inhibitors |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009492 (2-Phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-carbamic acid isopropyl ester, used in the control or prevention of illnesses such as cancer; anticarcinogenic agents |
| 01/10/2008 | US20080009489 Androgen receptor modulators and method of treating disease using the same |
| 01/10/2008 | US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion |
| 01/10/2008 | US20080009486 6-chloro-2'-(3-chlorophenyl)-4'-(2,2-dimethylpropyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione; mdm2 antagonists; have effects in p53 mutant cells by mdm2-p53 feedback control loop; anticarcinogenic agent; |
| 01/10/2008 | US20080009484 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/10/2008 | US20080009482 Novel compounds |
| 01/10/2008 | US20080009472 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009442 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis |
| 01/10/2008 | US20080009435 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2008 | US20080009068 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080008771 Nitric Oxide Dioxygenase Inhibitors |
| 01/10/2008 | US20080008768 Compositions and Methods for Inhibiting Sonic Hedgehog Activity |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008733 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/10/2008 | US20080008719 Methods and compositions for the treatment of prostate cancer |
| 01/10/2008 | US20080008716 Combined Pharmaceutical Composition Comprising an Anti-4-1BB Monoclonal Antibody and Chemotherapeutic Anti-Cancer Agent for Preventing and Treating Cancer Disease |
| 01/10/2008 | US20080008714 TWEAK receptor agonists as anti-angiogenic agents |
| 01/10/2008 | US20080008712 Novel Phosphorylated Sequences of the Phosphatase Cdc25B, Antibodies for Said Sequences and Use Thereof |
| 01/10/2008 | US20080008710 Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma |
| 01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/10/2008 | US20080008704 Methods of treating colorectal cancer with anti-epidermal growth factor antibodies |
| 01/10/2008 | US20080008693 Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008649 Gastrin Releasing Peptide Compounds |
| 01/10/2008 | US20080008648 Treatment of Cancer With a Novel Anti-Il13 Monoclonal Antibody |
| 01/10/2008 | CA2691346A1 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| 01/10/2008 | CA2657103A1 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 01/10/2008 | CA2657051A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/10/2008 | CA2656959A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | CA2656929A1 Triazine derivative compound and composition for treating cancer containing them |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/10/2008 | CA2656627A1 Sulfamatobenzothiophene derivatives |
| 01/10/2008 | CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656566A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656458A1 Indazole derivatives for the treatment of hsp90-induced diseases |
| 01/10/2008 | CA2656398A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 01/10/2008 | CA2656393A1 Method of using substituted piperidines that increase p53 activity |
| 01/10/2008 | CA2656364A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656290A1 Methods of using igf1r and abl kinase modulators |
| 01/10/2008 | CA2656135A1 Human il-4 muteins in cancer therapy |
| 01/10/2008 | CA2655720A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | CA2655552A1 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | CA2652058A1 Compositions and methods for modulating immune responses |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876186A1 Prophylactic/therapeutic agent for cancer |
| 01/09/2008 | EP1876180A2 Semi-synthetic ecteinascidins |
| 01/09/2008 | EP1876178A1 Cyanopyridine derivative and use thereof as medicine |
| 01/09/2008 | EP1875907A2 Use of yessotoxins in the treatment of allergic and asthmatic processes |
| 01/09/2008 | EP1875906A2 Therapeutic use of yessotoxins as human tumor cell growth inhibitors |
| 01/09/2008 | EP1875904A1 Methods |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874821A1 Combination of antibodies and glucocorticoids for treating cancer |
| 01/09/2008 | EP1874810A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 01/09/2008 | EP1874795A1 Compositions and uses of amooranin compounds |
| 01/09/2008 | EP1874789A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use |
| 01/09/2008 | EP1874788A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| 01/09/2008 | EP1874770A1 Phenylacetamides suitable as protein kinase inhibitors |
| 01/09/2008 | EP1874769A1 Novel aza- heterocycles serving as kinase inhibitors |
| 01/09/2008 | EP1874760A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer |
| 01/09/2008 | EP1874759A1 C-met modulators and methods of use |
| 01/09/2008 | EP1874755A2 Benzothiophene hydroxamic acid derivatives |
| 01/09/2008 | EP1874748A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators |
| 01/09/2008 | EP1874731A2 Quinobenzoxazine analogs and methods of using thereof |
| 01/09/2008 | EP1874723A2 New nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof |
| 01/09/2008 | EP1874407A2 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents |
| 01/09/2008 | EP1874352A2 Photodynamic therapy using chemoluminescence and a ligand-photosensitiser conjugate |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874324A1 Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
| 01/09/2008 | EP1874312A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1874297A1 Method of treating multiple myeloma using 17-aag or 17-ag or a prodrug of either in combination with a proteasome inhibitor |
| 01/09/2008 | EP1874296A2 Method of treating multiple myeloma using 17-aag of 17-ag of a prodrug of either |
| 01/09/2008 | EP1874294A1 Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions |
| 01/09/2008 | EP1874290A1 A process for the preparation of an oxaliplatin preparation |
| 01/09/2008 | EP1651287B1 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 01/09/2008 | EP1620409B1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1490053B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1371664B1 Wti modified peptide |
| 01/09/2008 | EP1282604B1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |